stockrowTeleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +28.9%
- EPS
- −17.3%
- Free cash flow
- +220.1%
- Total debt
- +47.7%
Quarter to June 2026, against a year earlier
Follow TFX
Alert me
Teleflex Incorporated (TFX) Revenue growth
Teleflex Incorporated's revenue growth over the twelve months to 30 June 2026 was 30.7%, up 13.4 percentage points from fiscal 2025 (17.3%). Over the past ten years it has ranged from −38.7% (fiscal 2023) to 17.3% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Instruments & Supplies industry median of 8.97% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 17.3% | 18.00 |
| FY2024 | −0.75% | 37.90 |
| FY2023 | −38.7% | (37.99) |
| FY2022 | −0.66% | (11.40) |
| FY2021 | 10.7% | 12.98 |
| FY2020 | −2.24% | (8.24) |
| FY2019 | 6.00% | (8.07) |
| FY2018 | 14.1% | (0.83) |
| FY2017 | 14.9% | 11.68 |
| FY2016 | 3.22% | 4.86 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 28.9% | (3.47) |
| Mar 2026 | 32.4% | 3.62 |
| Dec 2025 | 28.7% | (4.29) |
| Sep 2025 | 33.0% | 27.28 |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PLSE Pulse Biosciences, Inc compare | 90.1% |
| TFX Teleflex Incorporated | 30.7% |
| NVST Envista Holdings Corporation compare | 9.78% |
| MMSI Merit Medical Systems, Inc. compare | 9.06% |
| ATR AptarGroup, Inc. compare | 8.97% |
| BLCO Bausch + Lomb Corporation compare | 8.88% |
| AVTR Avantor, Inc. compare | 0.92% |
| ICUI ICU Medical, Inc. compare | −5.92% |
| MMED MiniMed Group, Inc. compare | — |
| Medical Instruments & Supplies industry median | 8.97% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on TFX
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement